COVID-19 Impact on Obesity Treating Neuromodulation System Market , Global Research Reports 2020-2021
- BMR3860354
- 96 Pages
- May 2020
- Medical Devices
North America region dominates the global obesity treating neuromodulation system market and is expected to continue to dominate the market over the forecast period. High adoption of neuromodulation system and increased regulatory approval of these devices in the region is expected to be factor for the growth of obesity treating neuromodulation system market. Europe is the second biggest market for the obesity treating neuromodulation system. Increasing prevalence of obesity and presence of market players is also driving the market of obesity treating neuromodulation system market in North America and Europe.
This report provides a complete quantitative data and qualitative analysis on the global market for Obesity Treating Neuromodulation System. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Obesity Treating Neuromodulation System was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Obesity Treating Neuromodulation System is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Obesity Treating Neuromodulation System, including the following market information:
Global Obesity Treating Neuromodulation System Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Obesity Treating Neuromodulation System Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Obesity Treating Neuromodulation System Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Obesity Treating Neuromodulation System Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)
Key market players
Major competitors identified in this market include Medtronic, Cyberonics, Abbott, BioControl Medical, Leptos Medical, ReShape Lifesciences, Nevro, Nuvectra, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Vagus Nerve Stimulator
Splanchnic Nerve Stimulator
Deep Brain Stimulator
Spinal Cord Stimulator
Autonomous Nerve Stimulator
Others
Based on the Application:
Hospitals
Clinics
Ambulatory Surgical Centers
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Obesity Treating Neuromodulation System Industry
1.7 COVID-19 Impact: Obesity Treating Neuromodulation System Market Trends
2 Global Obesity Treating Neuromodulation System Quarterly Market Size Analysis
2.1 Obesity Treating Neuromodulation System Business Impact Assessment - COVID-19
2.1.1 Global Obesity Treating Neuromodulation System Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Obesity Treating Neuromodulation System Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Obesity Treating Neuromodulation System Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Obesity Treating Neuromodulation System Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Obesity Treating Neuromodulation System Factory Price by Manufacturers
3.3 Location of Key Manufacturers Obesity Treating Neuromodulation System Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Obesity Treating Neuromodulation System Market
3.5 Key Manufacturers Obesity Treating Neuromodulation System Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Obesity Treating Neuromodulation System Segments, By Type
4.1 Introduction
1.4.1 Vagus Nerve Stimulator
1.4.2 Splanchnic Nerve Stimulator
1.4.3 Deep Brain Stimulator
1.4.4 Spinal Cord Stimulator
1.4.5 Autonomous Nerve Stimulator
1.4.6 Others
4.2 By Type, Global Obesity Treating Neuromodulation System Market Size, 2019-2021
4.2.1 By Type, Global Obesity Treating Neuromodulation System Market Size by Type, 2020-2021
4.2.2 By Type, Global Obesity Treating Neuromodulation System Price, 2020-2021
5 Impact of Covid-19 on Obesity Treating Neuromodulation System Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Ambulatory Surgical Centers
5.2 By Application, Global Obesity Treating Neuromodulation System Market Size, 2019-2021
5.2.1 By Application, Global Obesity Treating Neuromodulation System Market Size by Application, 2019-2021
5.2.2 By Application, Global Obesity Treating Neuromodulation System Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Medtronic
7.1.1 Medtronic Business Overview
7.1.2 Medtronic Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.1.3 Medtronic Obesity Treating Neuromodulation System Product Introduction
7.1.4 Medtronic Response to COVID-19 and Related Developments
7.2 Cyberonics
7.2.1 Cyberonics Business Overview
7.2.2 Cyberonics Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.2.3 Cyberonics Obesity Treating Neuromodulation System Product Introduction
7.2.4 Cyberonics Response to COVID-19 and Related Developments
7.3 Abbott
7.3.1 Abbott Business Overview
7.3.2 Abbott Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.3.3 Abbott Obesity Treating Neuromodulation System Product Introduction
7.3.4 Abbott Response to COVID-19 and Related Developments
7.4 BioControl Medical
7.4.1 BioControl Medical Business Overview
7.4.2 BioControl Medical Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.4.3 BioControl Medical Obesity Treating Neuromodulation System Product Introduction
7.4.4 BioControl Medical Response to COVID-19 and Related Developments
7.5 Leptos Medical
7.5.1 Leptos Medical Business Overview
7.5.2 Leptos Medical Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.5.3 Leptos Medical Obesity Treating Neuromodulation System Product Introduction
7.5.4 Leptos Medical Response to COVID-19 and Related Developments
7.6 ReShape Lifesciences
7.6.1 ReShape Lifesciences Business Overview
7.6.2 ReShape Lifesciences Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.6.3 ReShape Lifesciences Obesity Treating Neuromodulation System Product Introduction
7.6.4 ReShape Lifesciences Response to COVID-19 and Related Developments
7.7 Nevro
7.7.1 Nevro Business Overview
7.7.2 Nevro Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.7.3 Nevro Obesity Treating Neuromodulation System Product Introduction
7.7.4 Nevro Response to COVID-19 and Related Developments
7.8 Nuvectra
7.8.1 Nuvectra Business Overview
7.8.2 Nuvectra Obesity Treating Neuromodulation System Quarterly Production and Revenue, 2020
7.8.3 Nuvectra Obesity Treating Neuromodulation System Product Introduction
7.8.4 Nuvectra Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Obesity Treating Neuromodulation System Supply Chain Analysis
8.1.1 Obesity Treating Neuromodulation System Supply Chain Analysis
8.1.2 Covid-19 Impact on Obesity Treating Neuromodulation System Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Obesity Treating Neuromodulation System Distribution Channels
8.2.2 Covid-19 Impact on Obesity Treating Neuromodulation System Distribution Channels
8.2.3 Obesity Treating Neuromodulation System Distributors
8.3 Obesity Treating Neuromodulation System Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Obesity Treating Neuromodulation System Assessment
Table 9. COVID-19 Impact: Obesity Treating Neuromodulation System Market Trends
Table 10. COVID-19 Impact Global Obesity Treating Neuromodulation System Market Size
Table 11. Global Obesity Treating Neuromodulation System Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Obesity Treating Neuromodulation System Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Obesity Treating Neuromodulation System Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Obesity Treating Neuromodulation System Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Obesity Treating Neuromodulation System Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Obesity Treating Neuromodulation System Market Growth Drivers
Table 17. Global Obesity Treating Neuromodulation System Market Restraints
Table 18. Global Obesity Treating Neuromodulation System Market Opportunities
Table 19. Global Obesity Treating Neuromodulation System Market Challenges
Table 20. Key Manufacturers Obesity Treating Neuromodulation System Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Obesity Treating Neuromodulation System Market Size, 2019 (K Units) & (US$ Million)
Table 22. Obesity Treating Neuromodulation System Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Obesity Treating Neuromodulation System Manufacturing Plants
Table 24. Key Manufacturers Obesity Treating Neuromodulation System Market Served
Table 25. Date of Key Manufacturers Enter into Obesity Treating Neuromodulation System Market
Table 26. Key Manufacturers Obesity Treating Neuromodulation System Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Obesity Treating Neuromodulation System Market Size by Type, 2020, (US$ Million)
Table 29. Global Obesity Treating Neuromodulation System Market Size by Type, 2020 (K Units)
Table 30. Global Obesity Treating Neuromodulation System Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Obesity Treating Neuromodulation System Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Obesity Treating Neuromodulation System Market Size by Application, 2020-2021 (K Units)
Table 33. Global Obesity Treating Neuromodulation System Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Obesity Treating Neuromodulation System Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Obesity Treating Neuromodulation System Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Obesity Treating Neuromodulation System Market Size, 2019-2021 (K Units)
Table 38. US Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Obesity Treating Neuromodulation System Market Size, 2019-2021 (K Units)
Table 43. Germany Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Obesity Treating Neuromodulation System Market Size, 2019-2021 (K Units)
Table 50. China Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Obesity Treating Neuromodulation System Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. Medtronic Business Overview
Table 58. Medtronic Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Medtronic Obesity Treating Neuromodulation System Product
Table 60. Medtronic Response to COVID-19 and Related Developments
Table 61. Cyberonics Business Overview
Table 62. Cyberonics Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Cyberonics Obesity Treating Neuromodulation System Product
Table 64. Cyberonics Response to COVID-19 and Related Developments
Table 65. Abbott Business Overview
Table 66. Abbott Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Abbott Obesity Treating Neuromodulation System Product
Table 68. Abbott Response to COVID-19 and Related Developments
Table 69. BioControl Medical Business Overview
Table 70. BioControl Medical Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. BioControl Medical Obesity Treating Neuromodulation System Product
Table 72. BioControl Medical Response to COVID-19 and Related Developments
Table 73. Leptos Medical Business Overview
Table 74. Leptos Medical Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Leptos Medical Obesity Treating Neuromodulation System Product
Table 76. Leptos Medical Response to COVID-19 and Related Developments
Table 77. ReShape Lifesciences Business Overview
Table 78. ReShape Lifesciences Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. ReShape Lifesciences Obesity Treating Neuromodulation System Product
Table 80. ReShape Lifesciences Response to COVID-19 and Related Developments
Table 81. Nevro Business Overview
Table 82. Nevro Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Nevro Obesity Treating Neuromodulation System Product
Table 84. Nevro Response to COVID-19 and Related Developments
Table 85. Nuvectra Business Overview
Table 86. Nuvectra Obesity Treating Neuromodulation System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Nuvectra Obesity Treating Neuromodulation System Product
Table 88. Nuvectra Response to COVID-19 and Related Developments
Table 89. Obesity Treating Neuromodulation System Distributors List
Table 90. Obesity Treating Neuromodulation System Customers List
Table 91. Covid-19 Impact on Obesity Treating Neuromodulation System Customers
List of Figures
Figure 1. Obesity Treating Neuromodulation System Product Picture
Figure 2. Obesity Treating Neuromodulation System Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Obesity Treating Neuromodulation System Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Obesity Treating Neuromodulation System Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Obesity Treating Neuromodulation System Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Obesity Treating Neuromodulation System Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Obesity Treating Neuromodulation System Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Obesity Treating Neuromodulation System Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Obesity Treating Neuromodulation System Market Size Market Share, 2019-2021
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
